Eagle - I hope this makes sense.
Did you interpret his comments of 4-5 x Trofinetide deal, to be 4-5x the value of the Acadia deal OR did you think he meant 4-5x the value of Trofinetide as a product, which you could argue (and JP has stated) has a good comparative value in Skyclaris (Reata).
Sorry if that distinction is not clear.Just curious as to how others interpreted the comment. I admit my initial thoughts were the former valuation but then on further thought came to the conclusion that it does not make sense, when you consider his references to Reata for a single indication.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |